Previous 10 | Next 10 |
Mylan N.V. (MYL) Q1 2019 Results Earnings Conference Call May 07, 2019, 10:00 AM ET Company Participants Melissa Trombetta - Head, Global Investor Relations Heather Bresch - CEO Rajiv Malik - President Tony Mauro - Chief Commercial Officer Ken Parks - CFO Conference Call P...
Gainers: Bridgeline Digital (NASDAQ: BLIN ) +30% . Cohu (NASDAQ: COHU ) +27% . ATA (NASDAQ: ATAI ) +25% . ARCA biopharma (NASDAQ: ABIO ) +24% . SolarEdge Technologies (NASDAQ: SEDG ) +23% . Summit Wireless Technologies (NASDAQ: WISA ) +22% . Itron (NASDAQ: ITRI ) +21% . Sunwor...
The following slide deck was published by Mylan N.V. in conjunction with their 2019 Q1 earnings Read more ...
Mylan N.V. ( MYL -5.8% ) Q1 results : Revenues: $2,495.5M (-7.0%). More news on: Mylan N.V., Healthcare stocks news, Earnings news and commentary, Read more ...
Catalyst Pharmaceuticals (NASDAQ: CPRX ) -39% after FDA OKs Firdapse competitor. More news on: Catalyst Pharmaceuticals, Inc., Intersect ENT, Inc., TherapeuticsMD, Inc., Stocks on the move, Read more ...
Mylan (NASDAQ: MYL ): Q1 Non-GAAP EPS of $0.82 beats by $0.02 ; GAAP EPS of -$0.05. More news on: Mylan N.V., Earnings news and commentary, Healthcare stocks news, Read more ...
HERTFORDSHIRE, England and PITTSBURGH , May 7, 2019 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced its financial results for the three months ended March 31, 2019. First Quarter 2019 Financial Highlights U.S. GAAP diluted loss per ordinary share ("U.S. GAAP EPS") o...
ADNT , AES , AGN , AKRX , AMAG , ARMK , ARRY , ATH , ATKR , AVNS , BCC , BGCP , BLD , BR , BUD , CJ , CLVS , CNHI , CNK , CRL , CROX , CTLT , CWEN , DEA , DF , DNR , DPLO , DXPE , EGRX , EMR , ENR , EXPD , FI , GSKY , GTE , GTX , HAE , HSIC , ICL , IM...
NEW YORK, NY / ACCESSWIRE / May 6, 2019 / In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Louisiana-Pacific Corporation (NYSE: LPX), Toll Brothers Inc. (NYSE: TOL), Sincla...
A federal appeals court has ruled in Eli Lilly's ( LLY +0.9% ) favor, upholding an October 2017 decision by the USPTO's Patent Trial and Appeal Board that its patent covering a vitamin regimen for lung cancer med Alimta (pemetrexed) is valid. More news on: Eli Lilly and Company, Novart...
News, Short Squeeze, Breakout and More Instantly...
Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc. PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Nov. 6, 2020 HERTFORDSHIRE, England and PITTSBURGH , Nov. 6, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ...
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more. A long-awaited deal will soon be done. Pfizer (NYSE: PFE) and Mylan (NASDAQ: MYL) announced last week that the U.S. Federal Trade Commission has approved the planned merger of Pfizer's...
Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, Nov. 2, 2020 HERTFORDSHIRE , England, and PITTSBURGH, Nov. 2, 2020 /PRNews...